CTIM-30. EFFICACY OF PEMBROLIZUMAB IN PATIENTS WITH PITUITARY CARCINOMA: RESULTS FROM A PHASE II STUDY

Pituitary carcinoma is an aggressive tumor characterized by metastatic spread beyond the sellar region that leads to debilitating symptoms and poor survival. Pituitary carcinomas recur despite conventional multimodality treatments. Given the recent advances in the use of immune checkpoint inhibitors...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Majd, Nazanin, Waguespack, Steven, Filip, Janku, Fu, Siqing, Penas-Prado, Marta, Xu, Mingxuan, Alshawa, Anas, Kamiya-Matsuoka, Carlos, Raza, Shaan, McCutcheon, Ian, Aung, Naing
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Clinical Trials: Immunologic
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650354/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.164
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados